Walleye Trading
CLVS

Walleye Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Walleye Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-800
Closed -$2K – 5891
2022
Q1 		$2K Sell
800
-5,500
-87% -$10.8K ﹤0.01% 5218
2021
Q4 		$17K Sell
6,300
-12,400
-66% -$45.8K ﹤0.01% 4983
2021
Q3 		$83K Buy
18,700
+4,500
+32% +$21.7K ﹤0.01% 4461
2021
Q2 		$82K Buy
14,200
+8,500
+149% +$49.8K ﹤0.01% 4455
2021
Q1 		$40K Sell
5,700
-9,300
-62% -$62.4K ﹤0.01% 4399
2020
Q4 		$72K Sell
15,000
-2,300
-13% -$11.6K ﹤0.01% 4060
2020
Q3 		$101K Sell
17,300
-1,300
-7% -$7.78K ﹤0.01% 3402
2020
Q2 		$126K Buy
18,600
+17,900
+2,557% +$136K ﹤0.01% 3379
2020
Q1 		$4K Sell
700
-45,500
-98% -$365K ﹤0.01% 3815
2019
Q4 		$482K Buy
46,200
+9,200
+25% +$66.9K ﹤0.01% 2436
2019
Q3 		$145K Sell
37,000
-51,700
-58% -$418K ﹤0.01% 3133
2019
Q2 		$1.32M Buy
88,700
+87,700
+8,770% +$1.58M 0.01% 1376
2019
Q1 		$25K Buy
+1,000
New +$25.1K ﹤0.01% 3865
2018
Q4 		– Sell
-5,000
Closed -$147K – 5523
2018
Q3 		$147K Sell
5,000
-26,100
-84% -$1.01M ﹤0.01% 3970
2018
Q2 		$1.41M Buy
+31,100
New +$1.51M 0.01% 1714

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Walleye Trading's CLVS Position: Q1 2022 in Review

Walleye Trading sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 29,731 shares — an estimated $58.4K sold.

Walleye Trading first reported a position in CLVS in Q3 2015 and held it in 10 quarters. The position peaked at $671K in Q2 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Walleye Trading reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Walleye Trading sold 29,731 Clovis Oncology, Inc. shares in Q1 2022, an estimated $58.4K.
  • Walleye Trading first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Clovis Oncology, Inc. position peaked at $671K in Q2 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.